Cargando…

Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study

BACKGROUND: The relative cost of biologics in the treatment of autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis, is a key consideration for managed care payers. OBJECTIVES: Our objective was to estimate biologic costs and treatment patt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Tao, Shah, Neel, Deshpande, Gaurav, Tang, Derek H., Eisenberg, Debra F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127933/ https://www.ncbi.nlm.nih.gov/pubmed/27757919 http://dx.doi.org/10.1007/s40801-016-0093-2

Ejemplares similares

Biologic Cost per Effectively Treated Rheumatoid Arthritis Patient in a Large Managed Care Population: A Retrospective Cohort Study
por: Gu, Tao, et al.
Publicado: (2015)

Treatment Patterns and Annual Drug Costs of Biologic Therapies Across Indications from the Humana Commercial Database
por: Howe, Andrew, et al.
Publicado: (2014)

A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients
por: Chastek, Benjamin, et al.
Publicado: (2016)

Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid population
por: Bonafede, Machaon, et al.
Publicado: (2014)

Application of a validated algorithm to estimate the effectiveness and cost of biologics for rheumatoid arthritis in the US pharmacy benefit manager context
por: Wu, Ning, et al.
Publicado: (2015)

Economic burden of hepatitis B infection among patients with diabetes
por: Deshpande, Gaurav, et al.
Publicado: (2016)

Comparing the cost-per-QALYs gained and cost-per-DALYs averted literatures
por: Neumann, Peter J., et al.
Publicado: (2018)

Cost per cumulative clinical benefit of biologic therapies for patients with plaque psoriasis: a systematic review
por: Blauvelt, Andrew, et al.
Publicado: (2021)

The Cost of Nursing per Bed
Publicado: (1909)

Reducing the costs per patient by increasing the volume of cataract surgery
por: Malcolm, Jonathan, et al.
Publicado: (2022)

Adenomas per colonoscopy and adenoma per positive participant as quality indicators for screening colonoscopy
por: Wang, Shuo, et al.
Publicado: (2020)

Is an Impacted Tooth Per Se an Indication for Operation?
por: Harris, Leon
Publicado: (1920)

Evaluating the cost per child vaccinated with full versus fractional-dose inactivated poliovirus vaccine
por: Mvundura, Mercy, et al.
Publicado: (2019)

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
por: Weijers, Laure, et al.
Publicado: (2017)

Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment
por: Fishman, Jesse, et al.
Publicado: (2023)

Evaluation of the cost per patient per injection of botulinum toxin A in upper limb spasticity: comparison of two preparations in 19 countries
por: Roze, Stéphane, et al.
Publicado: (2012)

Mean cost per number needed to treat with tocilizumab plus methotrexate versus abatacept plus methotrexate in the treatment of rheumatoid arthritis in patients previously treated with methotrexate
por: Benucci, Maurizio, et al.
Publicado: (2017)

Costs of Tumor Necrosis Factor Blockers Per Treated Patient Using Real-World Drug Data in a Managed Care Population
por: Schabert, Vernon F., et al.
Publicado: (2013)

An examination of periodontal treatment and per member per month (PMPM) medical costs in an insured population
por: Albert, David A, et al.
Publicado: (2006)

Association of poor housing conditions with COVID-19 incidence and mortality across US counties
por: Ahmad, Khansa, et al.
Publicado: (2020)

Skin and Soft Tissue Infections and Associated Complications among Commercially Insured Patients Aged 0–64 Years with and without Diabetes in the U.S.
por: Suaya, Jose A., et al.
Publicado: (2013)

Critical care costs per patient-day are inversely related to the annual admission rate
por: Bhagwat, M, et al.
Publicado: (2006)

Cost-effectiveness of seven-days-per-week rehabilitation schedule for acute stroke patients
por: Morii, Yasuhiro, et al.
Publicado: (2023)

Projected US Urology Workforce per Capita, 2020-2060
por: Nam, Catherine S., et al.
Publicado: (2021)

Cost per Patient Achieving Treatment Targets and Number Needed to Treat with Tirzepatide Versus Semaglutide 1 mg in Patients with Type 2 Diabetes in the United States
por: Mody, Reema R., et al.
Publicado: (2023)

Cost per case or total cost? The potential of prevention of hand injuries in young children – Retrospective and prospective studies
por: Ljungberg, Elinor M, et al.
Publicado: (2008)

Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
por: Fournier, Marie, et al.
Publicado: (2019)

Determinants of per diem Hospital Costs in Mental Health
por: Wolff, Jan, et al.
Publicado: (2016)

Cost per responder of TNF-α therapies in Germany
por: Gissel, Christian, et al.
Publicado: (2013)

2414. Real-World Evaluation of Patient Characteristics and Outcomes of Patients Treated With Ceftolozane/Tazobactam Across 253 US Hospitals
por: Puzniak, Laura, et al.
Publicado: (2018)

Quality indicators in type 2 diabetes patient care: analysis per care-complexity level
por: Schneiders, Josiane, et al.
Publicado: (2019)

Association Between Medicare Star Ratings for Patient Experience and Medicare Spending per Beneficiary for US Hospitals
por: Trzeciak, Stephen, et al.
Publicado: (2017)

COVID-19 fatalities by zip codes and socioeconomic indicators across various U.S. regions
por: Sen-Crowe, Brendon, et al.
Publicado: (2021)

Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients
por: Rogers, John D., et al.
Publicado: (2022)

Benchmarking HIV Quality Measures Across US Payer Types
por: Priest, Julie L., et al.
Publicado: (2020)

General Practitioner Time Availability Per Inhabitant Per Year: A New Indicator to Measure Access to Primary Care
por: Beer, Laura, et al.
Publicado: (2022)

Do Loneliness and Per Capita Income Combine to Increase the Pace of Biological Aging for Black Adults across Late Middle Age?
por: Beach, Steven R. H., et al.
Publicado: (2022)

Accounting for the relationship between per diem cost and LOS when estimating hospitalization costs
por: Ishak, K Jack, et al.
Publicado: (2012)

A Systematic Review of Cost-Effectiveness Studies Reporting Cost-per-DALY Averted
por: Neumann, Peter J., et al.
Publicado: (2016)

Cost comparisons and factors related to cost per stay in intensive care units in Belgium
por: Bruyneel, Arnaud, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2frblv0lq8idb6qpuba0gtihhs